T2SARS-CoV-2™ Panel can detect multiple variants of the SARS-CoV

T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus

Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S.

T2SARS-CoV-2 Panel, which has demonstrated clinical sensitivity of 95 percent and specificity of 100 percent.

The T2SARS-CoV-2 Panel provides results in under two hours utilizing an upper respiratory swab sample. The test runs on the Company’s FDA-cleared and fully-automated T2Dx® Instrument, which is capable of performing seven tests simultaneously and up to sixty samples per day.

finance.yahoo.com/news/t2-biosystems-t2sars-cov-2-231900691.html

biotechbiotechnologybiotechsbiotechstockbiotechstocksbiotehnologyChart PatternsCoronavirus (COVID-19)Fundamental Analysissars-cov2sarscov2Trend Analysis

Also on:

Disclaimer